Has Ranee Angeli Lleva, MD received payments from drug or device companies?

Yes. Drug and device makers reported $375 in general payments to Ranee Angeli Lleva, MD across 19 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ranee Angeli Lleva, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ranee Angeli Lleva, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ranee Angeli Lleva, MD

Endocrinology, Diabetes & Metabolism · Greenwich, CTNPI 1578709143

Payments from drug & device makers

$375in general payments, 2019–2025

Across 19 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$265
Medtronic$95
Abbott$15

What the payments were for

Food & beverage$19452%
Education$18248%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	17	$265
Medtronic	1	$95
Abbott	1	$15

How this compares

$375 in reported general payments places this provider in the 30th percentile of 177 endocrinology, diabetes & metabolism providers in Connecticut.

See all endocrinology, diabetes & metabolism providers in Connecticut →

Medicare billing

Part B allowed, 2024

$467,694

Medicare patients

368

Services billed

15,699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	212	$253,566
MounjaroTirzepatide	181	$231,953
JardianceEmpagliflozin	98	$114,429
Tresiba Flextouch U-200Insulin Degludec	85	$90,497
JanuviaSitagliptin Phosphate	45	$63,949
Teriparatide	17	$38,684
TradjentaLinagliptin	43	$35,149
SynthroidLevothyroxine Sodium	232	$24,441
TrulicityDulaglutide	19	$18,423
Lyumjev Kwikpen U-200Insulin Lispro-Aabc	12	$17,069
InvokanaCanagliflozin	19	$17,006
Fiasp FlextouchInsulin Aspart (Niacinamide)	22	$14,066
Repatha SureclickEvolocumab	17	$13,529
FarxigaDapagliflozin Propanediol	15	$13,479
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7	18	$12,149

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Greenwich

Ania JastreboffNew Haven$2.2M
Ilja HulinskyBridgeport$1.6M
Gerald ShulmanNew Haven$1M
Karl InsognaNew Haven$903K
Clemens BergwitzNew Haven$735K
Egils BogdanovicsTorrington$608K
Robert ObersteinHartford$516K
Fadi Al-KhayerStorrs$489K
Silvio InzucchiNew Haven$461K
Francis WilsonNew Haven$415K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →